The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.

Side by side

Compound comparison

Check interactions →Open as saved/share list

RAD-140 / Testolone

Research chemical · Grade C

Goals
muscle, hormonal
Evidence
1 RCT / 0 animal / 0 in vitro
Routes
oral
WADA
S1
FDA
Not approved
Cancer caution
hard-stop
Typical dose
—
Half-life
—
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

Enclomiphene

Off-label · Grade C

Goals
hormonal, libido, muscle
Evidence
4 RCT / 1 animal / 2 in vitro
Routes
oral
WADA
S4
FDA
Not approved
Cancer caution
none
Typical dose
—
Half-life
short plasma half-life (estimated ~10-12 hours in humans under repeated dosing)
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

LGD-4033 / Ligandrol

Research chemical · Grade C

Goals
muscle, hormonal
Evidence
2 RCT / 0 animal / 0 in vitro
Routes
oral
WADA
S1
FDA
Not approved
Cancer caution
hard-stop
Typical dose
—
Half-life
Pharmacokinetics: half-life 24-36 hours
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

Ostarine (MK-2866)

Research chemical · Grade C

Goals
muscle, hormonal
Evidence
4 RCT / 0 animal / 0 in vitro
Routes
oral
WADA
S1
FDA
Not approved
Cancer caution
hard-stop
Typical dose
—
Half-life
—
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →